Kaleido Biosciences Executives
KLDODelisted Stock | USD 0.01 0.00 0.00% |
Kaleido Biosciences employs about 76 people. The company is managed by 3 executives with a total tenure of roughly 178 years, averaging almost 59.0 years of service per executive, having 25.33 employees per reported executive. Analysis of Kaleido Biosciences' management performance can provide insight into the firm performance.
Mark Wingertzahn Insider VP Devel |
Kimberly Hocknell Insider VP Operations |
Kaleido |
Kaleido Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.9993) % which means that it has lost $0.9993 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.8057) %, meaning that it created substantial loss on money invested by shareholders. Kaleido Biosciences' management efficiency ratios could be used to measure how well Kaleido Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Kaleido Biosciences Workforce Comparison
Kaleido Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 707. Kaleido Biosciences retains roughly 76.0 in number of employees claiming about 11% of equities under Health Care industry.
Kaleido Biosciences Notable Stakeholders
A Kaleido Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kaleido Biosciences often face trade-offs trying to please all of them. Kaleido Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kaleido Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark Wingertzahn | VP Devel | Profile | |
Kimberly Hocknell | VP Operations | Profile | |
LLM JD | Chief Advisor | Profile |
About Kaleido Biosciences Management Performance
The success or failure of an entity such as Kaleido Biosciences often depends on how effective the management is. Kaleido Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kaleido management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kaleido management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 76 people.
Kaleido Biosciences Workforce Analysis
Traditionally, organizations such as Kaleido Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kaleido Biosciences within its industry.Kaleido Biosciences Manpower Efficiency
Return on Kaleido Biosciences Manpower
Revenue Per Employee | 14.5K | |
Revenue Per Executive | 368K | |
Net Loss Per Employee | 1.2M | |
Net Loss Per Executive | 30.1M | |
Working Capital Per Employee | 822.9K | |
Working Capital Per Executive | 20.8M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Kaleido Pink Sheet
If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |